MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: A clinical validation study

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Bandettini, W Patricia ^a   Kellman, Peter ^a   Mancini, Christine ^a,b   Booker, Oscar Julian ^a,b   Vasu, Sujethra ^a   Leung, Steve W ^a   Wilson, Joel R ^a   Shanbhag, Sujata M ^a   Chen, Marcus Y ^a   Arai, Andrew E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SUBURBAN HOSPITAL   (United States)

Author keywords

Cardiovascular magnetic resonance; Late gadolinium enhancement; MultiContrast Delayed Enhancement; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM PENTETATE MEGLUMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; PRASUGREL; VASODILATOR AGENT; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC HEART INFARCTION; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; ENDOCARDIUM; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGE QUALITY; IMAGE RECONSTRUCTION; INSULIN TREATMENT; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; MULTICONTRAST DELAYED ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE PRICING; SENSITIVITY AND SPECIFICITY; SUBENDOCARDIUM; VALIDATION PROCESS;

ADULT; AGED; CONTRAST MEDIA; CORONARY CIRCULATION; FALSE POSITIVE REACTIONS; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84870170302     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-83     Document Type: Article

References (15)

1. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
2. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY, JACC Cardiovasc Imaging 2009 2 34 44 10.1016/j.jcmg.2008.09.010 19356530
3. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB, Circulation 2006 113 2733 2743 10.1161/CIRCULATIONAHA.105.570648 16754804 (Pubitemid 43947991)
4. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS, J Am Coll Cardiol 2008 51 1369 1374 10.1016/j.jacc.2007.11.071 18387438 (Pubitemid 351443083)
5. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. Kwon DH, Smedira NG, Rodriguez ER, Tan C, Setser R, Thamilarasan M, Lytle BW, Lever HM, Desai MY, J Am Coll Cardiol 2009 54 242 249 10.1016/j.jacc.2009.04.026 19589437
6. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H, J Am Coll Cardiol 2010 56 875 887 10.1016/j.jacc.2010.05.007 20667520
7. An improved MR imaging technique for the visualization of myocardial infarction. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM, Radiology 2001 218 215 223 11152805 (Pubitemid 32151298)
8. Myocardial infarct: depiction with contrast-enhanced MR imaging-comparison of gadopentetate and gadobenate. Schlosser T, Hunold P, Herborn CU, Lehmkuhl H, Lind A, Massing S, Barkhausen J, Radiology 2005 236 1041 1046 10.1148/radiol.2363040220 16055693 (Pubitemid 41170871)
9. Multi-contrast delayed enhancement provides improved contrast between myocardial infarction and blood pool. Kellman P, Chung YC, Simonetti OP, McVeigh ER, Arai AE, J Magn Reson Imaging 2005 22 605 613 10.1002/jmri.20426 16215969 (Pubitemid 41572712)
10. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
11. A weighted generalized score statistic for comparison of predictive values of diagnostic tests. Kosinski AS, Stat Med 2012 10.1002/sim.5587
12. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD, Circulation 2009 120 2069 2076 10.1161/CIRCULATIONAHA.109.852517 19901193
13. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ, J Am Coll Cardiol 2011 57 821 828 10.1016/j.jacc.2010.06.062 21310318
14. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, et al. JAMA 2012 308 890 896 10.1001/2012.jama.11089 22948699
15. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM, Circulation 2008 117 629 637 10.1161/CIRCULATIONAHA.107.723262 18212288